daratumumab
janssen
['lymphoma', 'daratumumab', 'leusm', 'lymsm', '1000']
phase 2 delphinus study (daratumumab (dara) in pediatric and young adult patients w/ r/r t-cell all or lymphoblastic #lymphoma (abstract 10001 #asco22) improved response rates w/ manageable ae's when compared to chemotherapy alone #childhoodcancer #pedcsm #leusm #lymsm 
#Cancer #Pharmacist (#OncoPharm) | #ChildhoodCancer #Advocate | Michigan ‘96 - #GoBlue | Tweets are not medical advice | Interests ???????????????????????